Knight Therapeutics | GUD - 营业费用

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 841.74M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	营业费用	更改		日
Acasti Pharma	USD 62.82M		59.73M	2025-09
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 1.19M		148K	2025-09
Aurora Cannabis	CAD 129.98M		16.05M	2025-12
Avita Medical	AUD 28.02M		1.55M	2025-12
Canopy Growth	CAD 87.2M		6.22M	2025-12
Cronos Group	USD 46.66M		4.93M	2026-03
Dianthus Therapeutics	USD 69.82M		29.14M	2025-12
Ionis Pharmaceuticals	USD 364M		54M	2026-03
IQVIA Holdings	USD 6.22B		4.53B	2026-03
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Moderna	USD 1.78B		242M	2026-03
Omeros	USD 59.16M		20.13M	2024-06
Organigram Holdings	CAD 83.66M		24.44M	2025-12
Organon & Co	USD 903M		387M	2026-03
Revvity	USD 628.34M		2.12M	2026-03
Tectonic Therapeutic	USD 21.52M		374K	2025-12
Tilray	USD 237.52M		17.34M	2025-09
Viatris	USD 3.54B		323.9M	2026-03
Xeris Pharmaceuticals	USD 69.03M		1.38M	2025-12